Certified by Founder Lodge
SeqOne Genomics
France - Montpellier, Occitanie
START UP
1 Disclosed Funding Rounds $22,600,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Providing genomic analysis to everybody.
SeqOne is a company focused on developing state-of-the-art genomic analysis tools for clinical applications in the fields of cancer and rare diseas
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 24 ,2022 | Series A | $22,600,000 |
Elaia
Omnes
IRDI Capital Investissement
Merieux Equity Partners
Software Club
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
